KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) EPS (Basic) (2016 - 2025)

Medpace Holdings' EPS (Basic) history spans 11 years, with the latest figure at $4.76 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 25.93% year-over-year to $4.76; the TTM value through Dec 2025 reached $15.64, up 19.75%, while the annual FY2025 figure was $15.64, 19.75% up from the prior year.
  • EPS (Basic) reached $4.76 in Q4 2025 per MEDP's latest filing, up from $3.95 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $4.76 in Q4 2025 to a low of $1.11 in Q2 2021.
  • Average EPS (Basic) over 5 years is $2.53, with a median of $2.33 recorded in 2023.
  • The largest YoY upside for EPS (Basic) was 63.24% in 2021 against a maximum downside of 2.8% in 2021.
  • A 5-year view of EPS (Basic) shows it stood at $1.39 in 2021, then soared by 56.83% to $2.18 in 2022, then increased by 16.97% to $2.55 in 2023, then surged by 48.24% to $3.78 in 2024, then grew by 25.93% to $4.76 in 2025.
  • Per Business Quant, the three most recent readings for MEDP's EPS (Basic) are $4.76 (Q4 2025), $3.95 (Q3 2025), and $3.16 (Q2 2025).